Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort
1 other identifier
observational
2,394
1 country
3
Brief Summary
Objectives and hypothesis The scale and diversity of chemicals in worldwide use today is vast. Many of these chemicals are released into the environment where they are found in air, water, soil, house dust, and in the food supply, resulting in exposure to humans. Characterizing the extent of exposure and the effects of exposure in vulnerable populations, such as pregnant women and children, is of the utmost importance as the chemical structure of many of these compounds resembles hormones such as estrogen, testosterone and thyroid hormone, affect neurodevelopment and other health effects. Here, we focus on few classes of compounds: heavy metals, volatile organic compounds (VOCs), brominated flame retardants (PBDEs) and phthalates. We will characterize the extent of exposure to pregnant women and their infants in Israel, where biomonitoring studies in the general population are scarce. We will also examine selected outcomes in pregnant women and their offspring in relation to these compounds, and to establish a biorepository for further studies. Specific Aims:
- 1.To assess Heavy metals, VOCs, PBDEs and phthalates body burdens through measurement of these chemicals in maternal and paternal serum and urine, cord blood, breastmilk and neonatal meconium among several representative sub-populations.
- 2.To examine associations between exposure to heavy metals, VOCs, PBDEs and phthalates and (a) pregnancy complications, (b) anthropometrics at birth (i.e. birth weight adjusted for gestational age, ponderal index, head circumference adjusted for gestational age), and (c) cryptorchidism incidence, (d) maternal and infant thyroid function.
- 3.To establish a bio repository of these media for future studies and to establish follow up methods for this cohort to later assess development and growth in the infants, toddlers and children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2013
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 6, 2014
CompletedFirst Posted
Study publicly available on registry
March 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 31, 2024
July 1, 2024
6.8 years
February 6, 2014
July 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measuring envinromental polutants, including heavy metals, VOCs, PBDEs and phthalates levels in collected samples
assessment of BFRs and phthalates body burdens through measurement of these chemicals in maternal and paternal serum and urine, cord blood, breastmilk and neonatal meconium among several representative sub-populations
48 months after end of specimens collection
Secondary Outcomes (1)
associations between exposure to nvinromental polutants, including heavy metals, VOCs, PBDEs and phthalates and few maternal and infant pregnancy and birth parameters and endocrine functions
48 months after end of specimens collection
Other Outcomes (1)
To establish a bio repository of these media for future studies
15 years after end of specimens collection
Eligibility Criteria
women and their partners attenting delivery room
You may qualify if:
- Israeli Arabs, Jews from Russia, Jews from Ethiopia, Jews with an Ashkenazic background and Jews with a Sephardic background
You may not qualify if:
- refuse to take part in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Rambam Medical Center
Haifa, Israel
Lis Medical Center
Tel Aviv, Israel
Assaf Harofeh Medical Center
Ẕerifin, 70300, Israel
Biospecimen
whole blood, serum, white cells, red blood cells, urine, breast milk, meconium
Study Officials
- PRINCIPAL INVESTIGATOR
Mati Berkovitch, Prof.
Assaf-Harofeh Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Days
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2014
First Posted
March 21, 2017
Study Start
September 1, 2013
Primary Completion
June 1, 2020
Study Completion
December 31, 2025
Last Updated
July 31, 2024
Record last verified: 2024-07